 | • レポートコード：C-GIR20G2765 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「ヒトDNAワクチンの世界市場2019年」は、グローバルにおけるヒトDNAワクチン市場を展望するレポートです。ヒトDNAワクチンのグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・ヒトDNAワクチンの市場概観 ・ヒトDNAワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ヒトDNAワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・ヒトDNAワクチンの世界市場規模 ・ヒトDNAワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・ヒトDNAワクチンのアメリカ市場規模推移 ・ヒトDNAワクチンのカナダ市場規模推移 ・ヒトDNAワクチンのメキシコ市場規模推移 ・ヒトDNAワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ヒトDNAワクチンのドイツ市場規模推移 ・ヒトDNAワクチンのイギリス市場規模推移 ・ヒトDNAワクチンのロシア市場規模推移 ・ヒトDNAワクチンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ヒトDNAワクチンの日本市場規模推移 ・ヒトDNAワクチンの中国市場規模推移 ・ヒトDNAワクチンの韓国市場規模推移 ・ヒトDNAワクチンのインド市場規模推移 ・ヒトDNAワクチンの東南アジア市場規模推移 ・ヒトDNAワクチンの南米市場分析（ブラジル、アルゼンチン等） ・ヒトDNAワクチンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ヒトDNAワクチンの種類別分析/販売量、売上、市場シェア（組換えタンパク質ワクチン、遺伝子ベースワクチン） ・ヒトDNAワクチンの用途別分析/市場規模（インフルエンザ、ヒトパピローマウイルス、HIV） ・ヒトDNAワクチンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ヒトDNAワクチンの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Human DNA Vaccines market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Human DNA Vaccines.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Human DNA Vaccines market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Human DNA Vaccines market by product type and applications/end industries.
Market Segment by Companies, this report covers
Indian Immunologicals
Plumbline Life Sciences
Zoties
GSK
Merck
Sanofi
Boehringer-Ingelheim
Elanco
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Recombinant Protein Vaccine
Gene-Based Vaccine
Market Segment by Applications, can be divided into
Influenza
Human Papillomavirus
HIV
Table of Contents
1 Human DNA Vaccines Market Overview
1.1 Product Overview and Scope of Human DNA Vaccines
1.2 Classification of Human DNA Vaccines by Types
1.2.1 Global Human DNA Vaccines Revenue Comparison by Types (2019-2024)
1.2.2 Global Human DNA Vaccines Revenue Market Share by Types in 2018
1.2.3 Recombinant Protein Vaccine
1.2.4 Gene-Based Vaccine
1.3 Global Human DNA Vaccines Market by Application
1.3.1 Global Human DNA Vaccines Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Influenza
1.3.3 Human Papillomavirus
1.3.4 HIV
1.4 Global Human DNA Vaccines Market by Regions
1.4.1 Global Human DNA Vaccines Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Human DNA Vaccines Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Human DNA Vaccines Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human DNA Vaccines Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Human DNA Vaccines Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human DNA Vaccines Status and Prospect (2014-2024)
1.5 Global Market Size of Human DNA Vaccines (2014-2024)
2 Company Profiles
2.1 Indian Immunologicals
2.1.1 Business Overview
2.1.2 Human DNA Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Indian Immunologicals Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.2 Plumbline Life Sciences
2.2.1 Business Overview
2.2.2 Human DNA Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Plumbline Life Sciences Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.3 Zoties
2.3.1 Business Overview
2.3.2 Human DNA Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Zoties Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.4 GSK
2.4.1 Business Overview
2.4.2 Human DNA Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GSK Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck
2.5.1 Business Overview
2.5.2 Human DNA Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Human DNA Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.7 Boehringer-Ingelheim
2.7.1 Business Overview
2.7.2 Human DNA Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Boehringer-Ingelheim Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.8 Elanco
2.8.1 Business Overview
2.8.2 Human DNA Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Elanco Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
3 Global Human DNA Vaccines Market Competition, by Players
3.1 Global Human DNA Vaccines Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Human DNA Vaccines Players Market Share
3.2.2 Top 10 Human DNA Vaccines Players Market Share
3.3 Market Competition Trend
4 Global Human DNA Vaccines Market Size by Regions
4.1 Global Human DNA Vaccines Revenue and Market Share by Regions
4.2 North America Human DNA Vaccines Revenue and Growth Rate (2014-2019)
4.3 Europe Human DNA Vaccines Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Human DNA Vaccines Revenue and Growth Rate (2014-2019)
4.5 South America Human DNA Vaccines Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Human DNA Vaccines Revenue and Growth Rate (2014-2019)
5 North America Human DNA Vaccines Revenue by Countries
5.1 North America Human DNA Vaccines Revenue by Countries (2014-2019)
5.2 USA Human DNA Vaccines Revenue and Growth Rate (2014-2019)
5.3 Canada Human DNA Vaccines Revenue and Growth Rate (2014-2019)
5.4 Mexico Human DNA Vaccines Revenue and Growth Rate (2014-2019)
6 Europe Human DNA Vaccines Revenue by Countries
6.1 Europe Human DNA Vaccines Revenue by Countries (2014-2019)
6.2 Germany Human DNA Vaccines Revenue and Growth Rate (2014-2019)
6.3 UK Human DNA Vaccines Revenue and Growth Rate (2014-2019)
6.4 France Human DNA Vaccines Revenue and Growth Rate (2014-2019)
6.5 Russia Human DNA Vaccines Revenue and Growth Rate (2014-2019)
6.6 Italy Human DNA Vaccines Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Human DNA Vaccines Revenue by Countries
7.1 Asia-Pacific Human DNA Vaccines Revenue by Countries (2014-2019)
7.2 China Human DNA Vaccines Revenue and Growth Rate (2014-2019)
7.3 Japan Human DNA Vaccines Revenue and Growth Rate (2014-2019)
7.4 Korea Human DNA Vaccines Revenue and Growth Rate (2014-2019)
7.5 India Human DNA Vaccines Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Human DNA Vaccines Revenue and Growth Rate (2014-2019)
8 South America Human DNA Vaccines Revenue by Countries
8.1 South America Human DNA Vaccines Revenue by Countries (2014-2019)
8.2 Brazil Human DNA Vaccines Revenue and Growth Rate (2014-2019)
8.3 Argentina Human DNA Vaccines Revenue and Growth Rate (2014-2019)
8.4 Colombia Human DNA Vaccines Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Human DNA Vaccines by Countries
9.1 Middle East and Africa Human DNA Vaccines Revenue by Countries (2014-2019)
9.2 Saudi Arabia Human DNA Vaccines Revenue and Growth Rate (2014-2019)
9.3 UAE Human DNA Vaccines Revenue and Growth Rate (2014-2019)
9.4 Egypt Human DNA Vaccines Revenue and Growth Rate (2014-2019)
9.5 Nigeria Human DNA Vaccines Revenue and Growth Rate (2014-2019)
9.6 South Africa Human DNA Vaccines Revenue and Growth Rate (2014-2019)
10 Global Human DNA Vaccines Market Segment by Type
10.1 Global Human DNA Vaccines Revenue and Market Share by Type (2014-2019)
10.2 Global Human DNA Vaccines Market Forecast by Type (2019-2024)
10.3 Recombinant Protein Vaccine Revenue Growth Rate (2014-2024)
10.4 Gene-Based Vaccine Revenue Growth Rate (2014-2024)
11 Global Human DNA Vaccines Market Segment by Application
11.1 Global Human DNA Vaccines Revenue Market Share by Application (2014-2019)
11.2 Human DNA Vaccines Market Forecast by Application (2019-2024)
11.3 Influenza Revenue Growth (2014-2019)
11.4 Human Papillomavirus Revenue Growth (2014-2019)
11.5 HIV Revenue Growth (2014-2019)
12 Global Human DNA Vaccines Market Size Forecast (2019-2024)
12.1 Global Human DNA Vaccines Market Size Forecast (2019-2024)
12.2 Global Human DNA Vaccines Market Forecast by Regions (2019-2024)
12.3 North America Human DNA Vaccines Revenue Market Forecast (2019-2024)
12.4 Europe Human DNA Vaccines Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Human DNA Vaccines Revenue Market Forecast (2019-2024)
12.6 South America Human DNA Vaccines Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Human DNA Vaccines Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Human DNA Vaccines Picture
Table Product Specifications of Human DNA Vaccines
Table Global Human DNA Vaccines and Revenue (Million USD) Market Split by Product Type
Figure Global Human DNA Vaccines Revenue Market Share by Types in 2018
Figure Recombinant Protein Vaccine Picture
Figure Gene-Based Vaccine Picture
Table Global Human DNA Vaccines Revenue (Million USD) by Application (2014-2024)
Figure Human DNA Vaccines Revenue Market Share by Applications in 2018
Figure Influenza Picture
Figure Human Papillomavirus Picture
Figure HIV Picture
Table Global Market Human DNA Vaccines Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Human DNA Vaccines Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Human DNA Vaccines Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Human DNA Vaccines Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Human DNA Vaccines Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Human DNA Vaccines Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Human DNA Vaccines Revenue (Million USD) and Growth Rate (2014-2024)
Table Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table Indian Immunologicals Human DNA Vaccines Type and Applications
Table Indian Immunologicals Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Plumbline Life Sciences Basic Information, Manufacturing Base and Competitors
Table Plumbline Life Sciences Human DNA Vaccines Type and Applications
Table Plumbline Life Sciences Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Zoties Basic Information, Manufacturing Base and Competitors
Table Zoties Human DNA Vaccines Type and Applications
Table Zoties Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Human DNA Vaccines Type and Applications
Table GSK Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Human DNA Vaccines Type and Applications
Table Merck Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Human DNA Vaccines Type and Applications
Table Sanofi Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer-Ingelheim Human DNA Vaccines Type and Applications
Table Boehringer-Ingelheim Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Elanco Basic Information, Manufacturing Base and Competitors
Table Elanco Human DNA Vaccines Type and Applications
Table Elanco Human DNA Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Global Human DNA Vaccines Revenue (Million USD) by Players (2014-2019)
Table Global Human DNA Vaccines Revenue Share by Players (2014-2019)
Figure Global Human DNA Vaccines Revenue Share by Players in 2017
Figure Global Human DNA Vaccines Revenue Share by Players in 2018
Figure Global Top 5 Players Human DNA Vaccines Revenue Market Share in 2018
Figure Global Top 10 Players Human DNA Vaccines Revenue Market Share in 2018
Figure Global Human DNA Vaccines Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Human DNA Vaccines Revenue (Million USD) by Regions (2014-2019)
Table Global Human DNA Vaccines Revenue Market Share by Regions (2014-2019)
Figure Global Human DNA Vaccines Revenue Market Share by Regions (2014-2019)
Figure Global Human DNA Vaccines Revenue Market Share by Regions in 2018
Figure North America Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure Europe Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure South America Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Table North America Human DNA Vaccines Revenue by Countries (2014-2019)
Table North America Human DNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure North America Human DNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure North America Human DNA Vaccines Revenue Market Share by Countries in 2018
Figure USA Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure Canada Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure Mexico Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Table Europe Human DNA Vaccines Revenue (Million USD) by Countries (2014-2019)
Figure Europe Human DNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure Europe Human DNA Vaccines Revenue Market Share by Countries in 2018
Figure Germany Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure UK Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure France Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure Russia Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure Italy Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Human DNA Vaccines Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Human DNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Human DNA Vaccines Revenue Market Share by Countries in 2018
Figure China Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure Japan Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure Korea Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure India Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Table South America Human DNA Vaccines Revenue by Countries (2014-2019)
Table South America Human DNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure South America Human DNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure South America Human DNA Vaccines Revenue Market Share by Countries in 2018
Figure Brazil Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure Argentina Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure Colombia Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Human DNA Vaccines Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Human DNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Human DNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Human DNA Vaccines Revenue Market Share by Countries in 2018
Figure Saudi Arabia Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure UAE Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure Egypt Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure Nigeria Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Figure South Africa Human DNA Vaccines Revenue and Growth Rate (2014-2019)
Table Global Human DNA Vaccines Revenue (Million USD) by Type (2014-2019)
Table Global Human DNA Vaccines Revenue Share by Type (2014-2019)
Figure Global Human DNA Vaccines Revenue Share by Type (2014-2019)
Figure Global Human DNA Vaccines Revenue Share by Type in 2018
Table Global Human DNA Vaccines Revenue Forecast by Type (2019-2024)
Figure Global Human DNA Vaccines Market Share Forecast by Type (2019-2024)
Figure Global Recombinant Protein Vaccine Revenue Growth Rate (2014-2019)
Figure Global Gene-Based Vaccine Revenue Growth Rate (2014-2019)
Table Global Human DNA Vaccines Revenue by Application (2014-2019)
Table Global Human DNA Vaccines Revenue Share by Application (2014-2019)
Figure Global Human DNA Vaccines Revenue Share by Application (2014-2019)
Figure Global Human DNA Vaccines Revenue Share by Application in 2018
Table Global Human DNA Vaccines Revenue Forecast by Application (2019-2024)
Figure Global Human DNA Vaccines Market Share Forecast by Application (2019-2024)
Figure Global Influenza Revenue Growth Rate (2014-2019)
Figure Global Human Papillomavirus Revenue Growth Rate (2014-2019)
Figure Global HIV Revenue Growth Rate (2014-2019)
Figure Global Human DNA Vaccines Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Human DNA Vaccines Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Human DNA Vaccines Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Human DNA Vaccines Revenue Market Forecast (2019-2024)
Figure Europe Human DNA Vaccines Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Human DNA Vaccines Revenue Market Forecast (2019-2024)
Figure South America Human DNA Vaccines Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Human DNA Vaccines Revenue Market Forecast (2019-2024)
ヒト狂犬病ワクチン市場：世界及び中国市場分析・予測（～2024年） Human Rabies Vaccines Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Human Rabies Vaccines industry with a focus on the Chinese market. The report provides key statistics on the market status of the Human Rabies Vaccines manu…- 予防的ヒト用ワクチン市場：世界及び中国市場分析・予測（～2024年） Prophylactic Human Vaccines Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Prophylactic Human Vaccines industry with a focus on the Chinese market. The report provides key statistics on the market status of the Prophylactic H…
- ヒト狂犬病ワクチン市場：世界及び中国市場分析・予測（～2024年） Human Rabies Vaccine Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Human Rabies Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Human Rabies Vaccine manufac…
- ヒトワクチンアジュバント市場：世界及び中国市場分析・予測（～2024年） Human Vaccine Adjuvants Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Human Vaccine Adjuvants industry with a focus on the Chinese market. The report provides key statistics on the market status of the Human Vaccine Adjuvant…
- 世界のバイオ医薬品およびワクチン市場予測（～2024年）：企業別、地域別、種類・用途別 Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases. Scope of the Report: The global Biopharmaceutical …